9.3a Given rapid changes in the global health architecture, how can countries manage the transition from aid, including methods for raising domestic revenues and other innovative sources of health financing.
Background
FCDO supports long-term research investment to tackle a range of global health problems. This spans areas such as preventable maternal and childhood mortality, comprehensive sexual and reproductive health and rights (SRHR), diseases of poverty (such as malaria, TB, HIV/AIDS and Neglected Tropical Diseases) emerging infectious diseases and diseases of epidemic potential.
We support the development of and equitable access to new vaccines, diagnostics and treatments; applied research to strengthen health systems and financing, and building inclusive and equitable partnerships for collaborative research. We recognise the scientific strengths of partner countries and the importance of localised, context specific research. Greater evidence and research are needed on how increased conflict and fragility, climate change and food insecurity are challenging efforts to make progress towards the health SDGs, especially for the most vulnerable people in LMICs.
Next steps
Get in touch with [email protected]
Topics
Related UKRI funded projects
-
Innovative spending: what should money be spent on to make global health innovations more effective in developing countries?
Health care in developing countries, certainly, but also even in developed countries-is ailing and in need of strengthening. While it is true that medical treatment has made astonishing advances over the years, the packa...
Funded by: ESRC
Lead research organisation: The Open University
Why might this be relevant?
Partially relevant as it focuses on innovative spending in global health but does not directly address methods for raising domestic revenues.
-
'Highlight' Health financing for universal health coverage in the era of shocks, monitoring risks and opportunities in Sub-Saharan Africa
Infectious disease outbreaks, such as COVID-19 can alter the levels and composition of health financing in low and middle income countries presenting risks and opportunities for progress towards universal health coverage...
Funded by: ESRC
Lead research organisation: London School of Hygiene and Tropical Medicine
Why might this be relevant?
Fully relevant as it specifically addresses health financing in the context of shocks like COVID-19 and its impact on universal health coverage.
-
GCRF:Thanzi la Onse (Health of All): Frameworks and analysis to ensure value for money health care - developing theory, changing practice
In all countries, difficult decisions are needed on how health care is financed, organised and provided for the benefit of populations. Decisions include how to determine and to secure appropriate levels of funding for h...
Funded by: GCRF
Lead research organisation: University of York
Why might this be relevant?
Partially relevant as it focuses on health care resource allocation and value for money, but does not directly address methods for raising domestic revenues.